Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2889
H.R.2889: Closing Loopholes for Orphan Drugs Act
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced June 13, 2017
- Latest Major Action June 16, 2017
- See the three similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
4 (2 Democrats, 2 Republicans)
Bill Version
- Introduced in House - June 13, 2017
Bill Summary
Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| June 16, 2017 |
Referred to the Subcommittee on Health.
|
| June 13, 2017 |
Referred to the House Committee on Energy and Commerce.
|
| June 13, 2017 |
Introduced in the House by Peter Welch (D-Vt.) |